Concepedia
Statistics
Publications
16
Citations
536
H-Index
13
Active since
2000
Affiliations
Tohoku University(Current)
Tohoku University Hospital
Tohoku Medical and Pharmaceutical University
Institute of Aging
Tokyo Medical University Hachioji Medical Center
Yuki Yoshino is an author at Tohoku University specializing in medicine, oncology, and cell biology.
Publications per year
2000–2024
DCK is frequently inactivated in acquired gemcitabine-resistant human cancer cells
Yuriko Saiki, Yuki Yoshino, Hiroko Fujimura et al. · Biochemical and Biophysical Research Communications · 2012 · 116 citations
Medicine, Cancer Biology, Oncology +12
<i>In vitro</i> treatment of human transforming growth factor‐β<sub>1</sub>‐treated monocyte‐derived dendritic cells with haptens can induce the phenotypic and functional changes similar to epidermal Langerhans cells in the initiation phase of allergic contact sensitivity reaction
Setsuya Aiba, Hideaki Manome, Yuki Yoshino et al. · Immunology · 2000 · 78 citations · Full text
Life Sciences, Cell Biology, Immunology +11
Inhibition of glycogen synthase kinase-3 beta induces apoptosis and mitotic catastrophe by disrupting centrosome regulation in cancer cells
Yuki Yoshino, Chikashi Ishioka · Scientific Reports · 2015 · 76 citations · Full text
Life Sciences, Cell Biology, Molecular Biology +17
microRNA-193a-3p is specifically down-regulated and acts as a tumor suppressor in BRAF-mutated colorectal cancer
Hidekazu Takahashi, Masanobu Takahashi, Shinobu Ohnuma et al. · BMC Cancer · 2017 · 32 citations · Full text
Medicine, Molecular Biology, Oncology +17
BRCA1-Interacting Protein OLA1 Requires Interaction with BARD1 to Regulate Centrosome Number
Yuki Yoshino, Huicheng Qi, Hiroki Fujita et al. · Molecular Cancer Research · 2018 · 32 citations
1–5 of 16